These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20647960)

  • 1. Androgens associated with advanced glycation end-products in postmenopausal women.
    Diamanti-Kandarakis E; Lambrinoudaki I; Economou F; Christou M; Piperi C; Papavassiliou AG; Creatsas G
    Menopause; 2010; 17(6):1182-7. PubMed ID: 20647960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women.
    Yasui T; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
    Clin Chim Acta; 2008 Dec; 398(1-2):43-7. PubMed ID: 18755173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.
    Davis SR; Robinson PJ; Moufarege A; Bell RJ
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):541-7. PubMed ID: 22106826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
    Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
    Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
    Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
    J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study.
    Golden SH; Ding J; Szklo M; Schmidt MI; Duncan BB; Dobs A
    Am J Epidemiol; 2004 Sep; 160(6):540-8. PubMed ID: 15353414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
    Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID; Rinaldi S; Dossus L; Gils CH; Peeters PH; Noord PA; Bueno-de-Mesquita HB; Johnsen SP; Overvad K; Olsen A; Tjønneland A; Boeing H; Lahmann PH; Linseisen J; Nagel G; Allen N; Roddam A; Bingham S; Khaw KT; Kesse E; Téhard B; Clavel-Chapelon F; Agudo A; Ardanaz E; Quiros JR; Amiano P; Martínez-Garcia C; Tormo MJ; Pala V; Panico S; Vineis P; Palli D; Tumino R; Trichopoulou A; Baibas N; Zilis D; Hémon B; Norat T; Riboli E; Kaaks R
    Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy.
    Debing E; Peeters E; Duquet W; Poppe K; Velkeniers B; Van den Brande P
    Eur J Endocrinol; 2007 Jun; 156(6):687-93. PubMed ID: 17535869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
    Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.
    Lambrinoudaki I; Christodoulakos G; Rizos D; Economou E; Argeitis J; Vlachou S; Creatsa M; Kouskouni E; Botsis D
    Eur J Endocrinol; 2006 Jun; 154(6):907-16. PubMed ID: 16728552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
    Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
    J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women.
    Glisic M; Rojas LZ; Asllanaj E; Vargas KG; Kavousi M; Ikram MA; Fauser BCJM; Laven JSE; Muka T; Franco OH
    Int J Cardiol; 2018 Jun; 261():189-195. PubMed ID: 29551255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.